Revelation Biosciences, Inc. (REVBW) stock

REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $16.05MP/E –Yield –

Revelation Biosciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Revelation Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.